Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Carterra is the leading provider of innovative Surface Plasmon Resonance (SPR) based technology for mAb discovery and characterization. Carterra’s high throughput LSA Array SPR platform combines patented microfluidics technology with real-time SPR, enabling single unattended runs for: >1,000 kinetic interactions; 384x384 epitope binning; >1,000 quantitation measurements; 384 epitope mapping. Combined with our unique data analysis and visualization software, the platform delivers the highest throughput and data quality available for mAb characterization, while using minimal sample. Carterra’s LSA provides mAb characterization throughput to match the output of the current generation of mAb expression platforms, enabling all antibodies to be rapidly and comprehensively screened so that unique epitopes and potential novel therapeutic candidates are not missed, while expanding IP coverage.